Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Increasing psychopharmacology clinical trial success rates with digital measures and biomarkers: Future methods.
NPP - digital psychiatry and neuroscience·2025
Same author
Regenerative Medicine: Case Study for Understanding and Anticipating Emerging Science and Technology.
NAM perspectives·2024
Related Experiment Video
Updated: May 12, 2026
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Chronic refractory dyspnoea--evidence based management.
Rachel Wiseman1, Debra Rowett, Peter Allcroft
1Department of Respiratory Medicine, Christchurch Hospital, New Zealand. rlwiseman@gmail.com
Australian Family Physician
|March 27, 2013
Summary
Managing chronic refractory dyspnoea involves treating reversible causes and non-pharmacological methods. Low-dose oral morphine is effective and safe for symptom relief in breathlessness.
Area of Science:
- Pulmonology
- Palliative Care
Background:
- Chronic refractory dyspnoea is persistent breathlessness despite maximal treatment of underlying causes.
- Commonly associated with COPD, heart failure, cancer, and interstitial lung diseases.
Purpose of the Study:
- To synthesize evidence for safe and effective symptomatic management of chronic refractory dyspnoea.
- To guide clinical practice through literature and guideline review.
Main Methods:
- Comprehensive literature search and review of existing clinical guidelines.
- Evidence synthesis for pharmacological and non-pharmacological interventions.
Main Results:
- Multifactorial nature of dyspnoea necessitates addressing all reversible causes.
- Pulmonary rehabilitation and breathing training are effective non-pharmacological options.
- Sustained-release oral morphine, titrated to effect, offers safe and effective symptom control.
Conclusions:
- Management requires a multimodal approach, addressing reversible etiologies.
- Non-pharmacological interventions are beneficial, particularly pulmonary rehabilitation for COPD.
- Opioid therapy, specifically low-dose oral morphine, is a safe and effective strategy for refractory dyspnoea, with benefits observed within 72 hours.